Dermbits

Dermbits

Welcome to Dermbits! Watch short videos of KOLs answering your questions
What do dermatologists sometimes overlook about apremilast when evaluating today’s treatment options?
0:56
Aug 3, 2026Psoriasis

What do dermatologists sometimes overlook about apremilast when evaluating today’s treatment options?

-

Which patients tend to surprise you with how well they do on apremilast?
0:54
Aug 3, 2026Psoriasis

Which patients tend to surprise you with how well they do on apremilast?

-

In what situations do you use apremilast alongside other psoriasis therapies?
0:55
Aug 3, 2026Psoriasis

In what situations do you use apremilast alongside other psoriasis therapies?

-

What has real-world experience taught us about apremilast that clinical trials alone could not?
0:56
Aug 3, 2026Psoriasis

What has real-world experience taught us about apremilast that clinical trials alone could not?

-

How do patient-defined treatment goals differ from clinician-defined treatment goals?
1:07
Aug 3, 2026Psoriasis

How do patient-defined treatment goals differ from clinician-defined treatment goals?

-

What aspects of living with psoriasis do clinicians sometimes underestimate?
1:27
Aug 3, 2026Psoriasis

What aspects of living with psoriasis do clinicians sometimes underestimate?

-

In an increasingly crowded psoriasis landscape, where does tildrakizumab fit for you clinically today?
1:08
Jul 24, 2026Psoriasis

In an increasingly crowded psoriasis landscape, where does tildrakizumab fit for you clinically today?

-

When you look at long-term data for tildrakizumab, what aspects feel most clinically meaningful in real-world practice?
1:01
Jul 24, 2026Psoriasis

When you look at long-term data for tildrakizumab, what aspects feel most clinically meaningful in real-world practice?

-

What types of treatment goals or patient expectations align particularly well with your experience using tildrakizumab?
1:09
Jul 24, 2026Psoriasis

What types of treatment goals or patient expectations align particularly well with your experience using tildrakizumab?

-

Has your experience with tildrakizumab changed the way you define treatment success in psoriasis?
1:20
Jul 24, 2026Psoriasis

Has your experience with tildrakizumab changed the way you define treatment success in psoriasis?

-

How has the definition of treatment success in psoriasis evolved over the last several years?
1:09
Jul 24, 2026Psoriasis

How has the definition of treatment success in psoriasis evolved over the last several years?

-

What aspects of psoriasis management become more challenging over the long term than they may initially appear?
2:13
Jul 24, 2026Psoriasis

What aspects of psoriasis management become more challenging over the long term than they may initially appear?

-

How do you decide when maintaining a patient successfully on therapy is more valuable than pursuing something newer or different?
1:35
Jul 24, 2026Psoriasis

How do you decide when maintaining a patient successfully on therapy is more valuable than pursuing something newer or different?

-

What types of psoriasis patients tend to fall into a treatment “gray zone,” and where has apremilast fit into your approach for those individuals?
1:06
Jul 6, 2026Psoriasis

What types of psoriasis patients tend to fall into a treatment “gray zone,” and where has apremilast fit into your approach for those individuals?

-

How do you set treatment goals with apremilast differently than you might with other systemic therapies?
0:52
Jul 6, 2026Psoriasis

How do you set treatment goals with apremilast differently than you might with other systemic therapies?

-

What have you learned about managing patients who improve on apremilast but do not achieve the level of response they initially hoped for?
1:16
Jul 6, 2026Psoriasis

What have you learned about managing patients who improve on apremilast but do not achieve the level of response they initially hoped for?

-

What factors most strongly influence whether patients feel successful on apremilast?
1:12
Jul 6, 2026Psoriasis

What factors most strongly influence whether patients feel successful on apremilast?

-

How do you approach psoriasis treatment decisions when objective measures and patient perception of disease severity do not align?
1:45
Jul 6, 2026Psoriasis

How do you approach psoriasis treatment decisions when objective measures and patient perception of disease severity do not align?

-

What challenges arise when treatment expectations are shaped by increasingly effective therapies for psoriasis?
0:41
Jul 6, 2026Psoriasis

What challenges arise when treatment expectations are shaped by increasingly effective therapies for psoriasis?

-

What is the mechanism of action of apremilast?
1:46
Jun 1, 2026Psoriasis

What is the mechanism of action of apremilast?

-

In what scenarios do you find apremilast works best alongside other therapies rather than as monotherapy?
1:47
Jun 1, 2026Psoriasis

In what scenarios do you find apremilast works best alongside other therapies rather than as monotherapy?

-

What do dermatologists sometimes overlook about apremilast when focusing on newer therapies?
2:13
Jun 1, 2026Psoriasis

What do dermatologists sometimes overlook about apremilast when focusing on newer therapies?

-

What counseling strategies have made the biggest difference in helping patients get through the first few weeks on apremilast?
2:02
Jun 1, 2026Psoriasis

What counseling strategies have made the biggest difference in helping patients get through the first few weeks on apremilast?

-

How do functionally sensitive areas like hands, feet, or scalp change your threshold for moving beyond topicals?
1:36
Jun 1, 2026Psoriasis

How do functionally sensitive areas like hands, feet, or scalp change your threshold for moving beyond topicals?

-